A Study On The Sickle Cell Disease

Sickle Cell Disease is an illness that affects people all across the globe. This paper will give a description of the sickness through the discussion of the causes, symptoms, and possible cures. Sickle Cell Disease (SCD) is a "group of inherited red blood cell disorders."(1) These disorders can have various afflictions, such as pain, damage and a low blood count--Sickle Cell Anemia.

Sickle cell anemia is a hereditary disorder that mostly affects people of African ancestry, but also occurs in other ethnic groups, including people who are of Mediterranean and Middle Eastern descent. More than 70,000 Americans have sickle cell anemia. And about 2 million Americans - and one in 12 African Americans - have sickle cell trait (this means they carry one gene for the disease, but do not have the disease itself).

Sickle cell disease is a disease that is most prevalent in people of African descent along with people of Mediterranean and Middle Eastern origin. This disease is known to affect about 70, 000 Americans and about 2 million people carry the trait (meaning that, they carry a single gene mutation).

Health care disparity with sickle cell Disease Patient’s    Thesis Statement.   Barriers to racial health care equity include the health care system (insurance, funding), the patient (poor health literacy, fear, mistrust), the community (awareness, advocacy), and the providers (bias, attitudes, expectations, stereotyping).      Sickle cell disease (SCD) is the most prevalent genetic hematological disorder worldwide predominantly affecting populations of West African and African Caribbean descent, as well as populations of Asian, Middle Eastern, and Mediterranean origins (Burne, 2008). It affects about 80,000 people in the United States and is the most common inherited blood disorder (O’Cconnor, 2014). It affects 1 in every 500 births of African

It has always been assumed that genetics and lifestyle play a major role in the presence of health disparities and health care issue that affects African-Americans. This paper provides a historical background to a key disease more prevalent in the African American community, Sickle Cell Anemia, the history behind the disease, genetic mechanisms that influences once probability of inheritance and in-depth treatment on how to manage, prevent and sustain a healthy lifestyle when dealing with sickle cell anemia. Sickle cell anemia is a hereditary disease that alters important aspects of the body physiologically and can be inherited via genes. Sickle cell disease (SCD) was first identified in 1910 and has existed in the continent of Africa for five

Hypothesis: African-American parents with the Sickle Cell Trait have the greatest risk of passing Sickle Cell Anemia to their offspring.

Sickle cell disease (SCD) occurs in 1 out of every 365 African American births compared to 1 out of 16,000 Hispanic-American births (1). SCD is a group of red blood cell disorders in which patients have a sickle or moon-shaped red blood cell due to an abnormal S hemoglobin. While sickle cell disease is relatively rare in American births, this is an alarming statistic among people of Sub-Saharan (west and central) African descent. An interesting fact is that SCD occurs more often among people from parts of the world where malaria is or was common, such as Sub-Saharan Africa (1). In addition, it is believed that people who carry the sickle cell trait are less likely to have

The sickle cell disease affects about 100,000 people in the America. The most common ethnic group the sickle cell anemia is seen in is African Americans and Hispanics. Approximately one in every ten African American and one in every one hundred Hispanic Americans have the sickle cell trait. Approximately two million people have the sickle cell trait in America. Approximately one in five- hundred African Americans and one in one thousand to one thousand and four hundred Hispanic-Americans have sickle cell disease. No universal cure has been found for sickle cell anemia (“Facts About Sickle Cell Trait And Disease,”n.d.). Sickle cell anemia affects many Americans and a universal cure needs to be found.

Sickle Cell Disease is normally viewed as a “black” disease, yet the primary areas of geographic origin of the disease are the Mediterranean Basin and Central Africa, regions that are primarily “white”.

Sickle cell anemia affects a wide range of demographics, from young to old. However, there are specific groups of people who are likely more prone to this disease than any other group. This disease affects millions of people worldwide regardless of age, but it is particularly common amongst those who derive from specific regions of the world. Sickle cell anemia is most common in those whose ancestors are derived from the sub-Saharan region of Africa. Furthermore, other regions that are known to have a high number of people containing sickle cell anemia are from Mediterranean countries, the Arabian Peninsula, and Spanish-speaking regions as well ("Who Is at Risk for Sickle Cell Anemia?"). This disease originated from the sub-Saharan region of Africa, and later migrated to other areas through the spreading of other diseases such as malaria. This is due to the fact that sickle cell disease occurs habitually in areas that are prone to diseases such as malaria. Although this disease can affect anyone, the highest cases of sickle cell anemia were found in African-Americans than in any other race. In the United States, sickle cell disease affects about 70,000 to 100,000 Americans ("Who Is at Risk for Sickle Cell Anemia?"). The statistics show that 1 out of every 500 births is affected by sickle cell disease for African-Americans. For the Hispanics, 1 out of every 36,000 births is prone to sickle cell disease ("Who Is at Risk for Sickle Cell Anemia?"). The age ranges for which a

Sickle cell disease is a chronic condition that a person can inherit from their parents in which it effects the globular structure of the patients red blood cells. A more sickle shaped structure, which can alter a person’s blood flow, replaces the more common globular structure. This impairment in blood flow can lead to blood clots, severe debilitating pain and damage to vital organs such as the liver, kidney and spleen. This disease currently affects over 90,000 people in the United States, with the majority of them being African American and

Thousands of years ago, a genetic mutation occurred in people from the Mediterranean basin, India, Africa, and the Middle East. As the Malaria Epidemic attacked people of these countries, carriers of the defective hemoglobin gene survived. Carrying one defective gene means that a person has a sickle cell trait. Two parents with the trait will produce a child with sickle cell anemia. People of these countries migrated and spread to other areas. In the Western Hemisphere, where malaria is not much of a problem, having the abnormal hemoglobin gene has lost its advantage. Any child born from parents that each has the trait will be born with the disease.

Sickle-cell disease majorly affects the hemoglobin that is present in our blood. The job of hemoglobin is to help transport oxygen and carbon dioxide to and from the cells throughout our body. Hemoglobin is present specifically in our red blood cells. Each red blood cell contains two hundred and eighty million hemoglobin molecules. Red blood cells normal shape is a biconcave shape because of the lack of many organelles and a nucleus. The shape is so important to a red blood cells functioning that if it is not shaped normally it has major consequences. The shape helps them to fit through capillaries easier and also allows for an increased surface area which results in easier gas exchange. Sickle-cell disease is a genetic disease that causes issues in the oxygen/carbon dioxide carrying hemoglobin molecules that are present in our red blood cells.

The term sickle cell disease (SCD) involves a range of disorders characterized by the occurrence of at least one haemoglobin S (Hb S) allele and a second abnormal allele allowing abnormal haemoglobin polymerization leading to a symptomatic disorder. Most patients often are healthy at early stages in their life and become symptomatic later on in their life time. Fetal haemoglobin levels decrease and haemoglobin s levels increase. Sickle cell disease is determined at conception, when a person acquires his/her genes from the parents. Sickle cell disease cannot be caught, acquired, or otherwise transmitted.

Sickle-cell disease is more prevalent in ethnic groups of India who share a genetic link with African communities, where the prevalence of SCD ranges from 9.4 to 22.2% in widespread areas of Chhattisgarh, Madhya Pradesh and Rajasthan .[88] It is also prevalent among Tharu (people of Nepal and India) though, they have a sevenfold less occurrence of malaria even with living in a malaria infested